BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Job Trends

  Fresenius Kabi to Create Hundreds of New Jobs in North Carolina With $100M Expansion

  Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Why Bay Area’s Intuitive Surgical Could be the Top Medtech Stock Right Now

  Over the years, Intuitive Surgical has carved out a place for itself as one of the few providers of minimally-invasive, robotically-assisted surgical equipment.

  November 21, 2017

   · 

  1 min read
• 

  Genetown

  Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year

  In less than four years, Corbus has grown from a tiny startup to a public company with 60 employees and four assets in the clinic.

  November 21, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  FDA

  The FDA Cleared 19 Spine Devices in October Alone

  A look at the 19 spine-related medical devices the FDA cleared in October.

  November 21, 2017

   · 

  1 min read
• 

  FDA

  GlaxoSmithKline’s ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen

  HIV patients have a new maintenance drug in their arsenal of medication.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  This Could Hurt Amazon’s Foray Into the Drug Industry

  Amazon is hawking dubious health products, including some that have been criticized by regulators and may even be illegal.

  November 21, 2017

   · 

  1 min read
• 

  Drug Development

  Stanford, NCI Researchers Discover New CAR-T Target With Early Study Data

  Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.

  November 21, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Unexpected Safety Issue Forces Bay Area’s Ardelyx to Ditch Phase III Hyperkalemia Drug

  Ardelyx updated two of its programs today.

  November 21, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year

  Investors have had a decent year, but some have much to be grateful for this Thanksgiving.

  November 21, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Medtech Innovative Health Solutions to Create New Jobs in Expansion

  Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown